Novartis Ag (NVS) Times Interest Earned (2009 - 2026)
Novartis Ag's (NVS) quarterly Times Interest Earned came in at 10.28 in Q2 2026, up 38.91% year-over-year from 7.4 in Q2 2025, and up 16.73% quarter-over-quarter from 12.35 in Q1 2026.
Powered by 
Analysis
Novartis Ag (NVS) Times Interest Earned (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Times Interest Earned across 18 years of filings, most recently posting 10.28 for Q2 2026.
- In Q2 2026, Times Interest Earned rose 38.91% year-over-year to 10.28; the TTM figure through Jun 2026 stood at 13.99 (down 5.84% YoY), while the FY2025 annual figure was 15.42, down 6.68% from the prior year.
- Times Interest Earned came in at 10.28 for Q2 2026 at Novartis Ag, up from 12.35 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of 7.94 in Q3 2023 to a low of 24.16 in Q1 2023.
- Average Times Interest Earned over 5 years is 14.13, with a median of 13.37 recorded in 2023.
- Year-over-year, Times Interest Earned soared 44.62% in 2022 and tumbled 73.1% in 2024.
- Over 5 years, Times Interest Earned stood at 10.44 in 2022, then slipped by 7.9% to 11.26 in 2023, then increased by 10.29% to 10.11 in 2024, then tumbled by 68.65% to 17.04 in 2025, then surged by 39.67% to 10.28 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were 10.28 in Q2 2026, 12.35 in Q1 2026, and 17.04 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 3.65 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | -21.24 |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 8.18 |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 1,199.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.28 |
| Mar 31, 2026 | -12.35 |
| Dec 31, 2025 | -17.04 |
| Sep 30, 2025 | -16.02 |
| Jun 30, 2025 | -16.83 |
| Mar 31, 2025 | -17.27 |
| Dec 31, 2024 | -10.11 |
| Sep 30, 2024 | -13.74 |
| Jun 30, 2024 | -16.32 |
| Mar 31, 2024 | -23.46 |
| Dec 31, 2023 | -11.26 |
| Sep 30, 2023 | -7.94 |
| Jun 30, 2023 | -13.00 |
| Mar 31, 2023 | -24.16 |
| Dec 31, 2022 | -10.44 |
| Sep 30, 2022 | -8.86 |
| Jun 30, 2022 | -11.03 |
| Mar 31, 2022 | -14.19 |
| Dec 31, 2021 | -14.63 |
| Sep 30, 2021 | -16.00 |